Literature DB >> 14595002

Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro.

Veneracion G Cabana1, Ning Feng, Catherine A Reardon, John Lukens, Nancy R Webb, Frederick C de Beer, Godfrey S Getz.   

Abstract

Serum amyloid A (SAA) circulates bound to HDL3 during the acute-phase response (APR), and recent evidence suggests that elevated levels of SAA may be a risk factor for cardiovascular disease. In this study, SAA-HDL was produced in vivo during the APR and without the APR by injection of an adenoviral vector expressing human SAA-1. SAA-HDL was also produced in vitro by incubating mouse HDL with recombinant mouse SAA and by SAA-expressing cultured hepatoma cells. Whether produced in vivo or in vitro, SAA-HDL floated at a density corresponding to that of human HDL3 (d 1.12 g/ml) separate from other apolipoproteins, including apolipoprotein A-I (apoA-I; d 1.10 g/ml) when either apoA-I or apolipoprotein E (apoE) was present. In the absence of both apoA-I and apoE, SAA was found in VLDL and LDL, with low levels in the HDL and the lipid-poor fractions suggesting that other HDL apolipoproteins are incapable of facilitating the formation of SAA-HDL. We conclude that SAA does not exist in plasma as a lipid-free protein. In the presence of HDL-associated apoA-I or apoE, SAA circulates as SAA-HDL with a density corresponding to that of human HDL3. In the absence of both apoA-I and apoE, SAA-HDL is not formed and SAA associates with any available lipoprotein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595002     DOI: 10.1194/jlr.M300414-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  21 in total

1.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

2.  Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.

Authors:  Tomáš Vaisar; Chongren Tang; Ilona Babenko; Patrick Hutchins; Jake Wimberger; Anthony F Suffredini; Jay W Heinecke
Journal:  J Lipid Res       Date:  2015-05-20       Impact factor: 5.922

3.  Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice.

Authors:  Min Liu; David G Kuhel; Ling Shen; David Y Hui; Stephen C Woods
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-29       Impact factor: 3.619

4.  Serum amyloid A is not incorporated into HDL during HDL biogenesis.

Authors:  Ailing Ji; Xuebing Wang; Victoria P Noffsinger; Drew Jennings; Maria C de Beer; Frederick C de Beer; Lisa R Tannock; Nancy R Webb
Journal:  J Lipid Res       Date:  2020-01-08       Impact factor: 5.922

5.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

6.  A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A.

Authors:  Ronan Hugh Mullan; Jennifer McCormick; Mary Connolly; Barry Bresnihan; Douglas James Veale; Ursula Fearon
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

7.  Some acute phase reactants and cholesterol levels in serum of patient with Crimean-Congo haemorrhagic fever.

Authors:  Ismail Sari; Sevtap Bakir; Aynur Engin; Hüseyin Aydin; Omer Poyraz
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

8.  The Relationship Among the Level of Serum Amyloid A, High-Density Lipoprotein and Microalbuminuria in Patients With Familial Mediterranean Fever.

Authors:  Ali Ugur Uslu; Bahattin Aydin; Ibrahim Serhat Icagasıoğlu; Sevket Balta; Köksal Deveci; Filiz Alkan; Gürsel Yıldız; Ali Sahin
Journal:  J Clin Lab Anal       Date:  2016-04-19       Impact factor: 2.352

9.  CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells.

Authors:  Irina N Baranova; Alexander V Bocharov; Tatyana G Vishnyakova; Roger Kurlander; Zhigang Chen; Dong Fu; Irwin M Arias; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

10.  Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.

Authors:  Patricia G Wilson; Joel C Thompson; Nancy R Webb; Frederick C de Beer; Victoria L King; Lisa R Tannock
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.